| 1 |
Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association [J]. Circulation, 2016, 133(4): e38-360.
|
| 2 |
Williams AR, Hatzistergos KE, Addicott B, et al. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction [J]. Circulation, 2013, 127(2): 213-223.
|
| 3 |
Tang YL, Wang YJ, Chen LJ, et al. Cardiac-derived stem cell-based therapy for heart failure: progress and clinical applications [J]. Exp Biol Med (Maywood), 2013, 238(3): 294-300.
|
| 4 |
Sanganalmath SK, Bolli R. Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions[J]. Circ Res, 2013, 113(6): 810-834.
|
| 5 |
Abdel-Latif A, Bolli R, Tleyjeh IM, et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis [J]. Arch Intern Med, 2007, 167(10): 989-997.
|
| 6 |
Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts [J]. Science, 1998, 282(5391): 1145-1147.
|
| 7 |
李松，苗增民，高佩安, 等. 胚胎干细胞技术[J]. 生物学通报, 2006, 41(7): 15-16.
|
| 8 |
Baldwin T. Morality and human embryo research. Introduction to the Talking Point on morality and human embryo research [J]. EMBO Rep, 2009, 10(4): 299-300.
|
| 9 |
张学峰，张美荣，胡建霞, 等. 异种脐带间充质干细胞静脉应用的安全性[J]. 中国组织工程研究与临床康复, 2010, 14(32): 5971-5975.
|
| 10 |
Leistner DM, Fischer-Rasokat U, Honold J, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy [J]. Clin Res Cardiol, 2011, 100(10): 925-934.
|
| 11 |
Musialek P, Mazurek A, Jarocha D, et al. Myocardial regeneration strategy using Wharton′s jelly mesenchymal stem cells as an off-the-shelf ′unlimited′therapeutic agent: results from the Acute Myocardial Infarction First-in-Man Study[J].Postepy Kardiol Interwencyjnej, 2015, 11(2): 100-107.
|
| 12 |
Aguilera V, Briceño L, Contreras H, et al.Endothelium trans differentiated from Wharton′s jelly mesenchymal cells promote tissue regeneration: potential role of soluble pro-angiogenic factors [J]. PLoS One, 2014, 9(11): e111025.
|
| 13 |
Gao LR, Chen Y, Zhang NK, et al. Intracoronary infusion of Wharton′s jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial [J]. BMC Med, 2015, 13: 162.
|
| 14 |
Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells [J]. Mol Biol Cell, 2002, 13(12): 4279-4295.
|
| 15 |
Henry TD, Pepine CJ, Lambert CR, et al. The Athena trials: autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction [J]. Catheter Cardiovasc Interv, 2017, 89(2): 169-177.
|
| 16 |
Terrovitis J, Lautamäki R, Bonios M, et al. Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery [J]. J Am Coll Cardiol, 2009, 54(17): 1619-1626.
|
| 17 |
Blocklet D, Toungouz M, Berkenboom G, et al. Myocardial homing of nonmobilized peripheral-blood CD34＋ cells after intracoronary injection [J]. Stem Cells, 2006, 24(2): 333-336.
|
| 18 |
Hou D, Youssef EA, Brinton TJ, et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials [J]. Circulation, 2005, 112(9 Suppl): I150-156.
|
| 19 |
Mangi AA, Noiseux N, Kong D, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts [J]. Nat Med, 2003, 9(9): 1195-1201.
|
| 20 |
Heeger CH, Jaquet K, Thiele H, et al. Percutaneous, transendocardial injection of bone marrow-derived mononuclear cells in heart failure patients following acute ST-elevation myocardial infarction: ALSTER-Stem Cell trial [J]. EuroIntervention, 2012, 8(6): 732-742.
|
| 21 |
Freyman T, Polin G, Osman H, et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction [J]. Eur Heart J, 2006, 27(9): 1114-1122.
|
| 22 |
Gyöngyösi M, Wojakowski W, Lemarchand P, et al. Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data [J]. Circ Res, 2015, 116(8): 1346-1360.
|
| 23 |
Delewi R, Hirsch A, Tijssen JG, et al. Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis [J]. Eur Heart J, 2014, 35(15): 989-998.
|
| 24 |
Fisher SA, Doree C, Mathur A, et al. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure [J]. Cochrane Database Syst Rev, 2016, 12: CD007888.
|
| 25 |
Tian T, Chen B, Xiao Y, et al. Intramyocardial autologous bone marrow cell transplantation for ischemic heart disease: a systematic review and meta-analysis of randomized controlled trials [J]. Atherosclerosis, 2014, 233(2): 485-492.
|
| 26 |
Lee SH, Hong JH, Cho KH, et al. Discrepancy between short-term and long-term effects of bone marrow-derived cell therapy in acute myocardial infarction: a systematic review and meta-analysis [J]. Stem Cell Res Ther, 2016, 7(1): 153.
|
| 27 |
Fisher SA, Doree C, Mathur A, et al. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure [J]. Cochrane Database Syst Rev, 2016, 12: CD007888.
|
| 28 |
Traverse JH, Henry TD, Pepine CJ, et al. Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial [J]. JAMA, 2012, 308(22): 2380-2389.
|
| 29 |
Wang Z, Wang L, Su X, et al. Rational transplant timing and dose of mesenchymal stromal cells in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials [J]. Stem Cell Res Ther, 2017, 8(1): 21.
|
| 30 |
Malliaras K, Li TS, Luthringer D, et al. Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells [J]. Circulation, 2012, 125(1): 100-112.
|
| 31 |
Florea V, Rieger AC, DiFede DL, et al. Dose comparison study of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy (The TRIDENT Study) [J]. Circ Res, 2017, 121(11): 1279-1290.
|
| 32 |
Suncion VY, Ghersin E, Fishman JE, et al. Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: an analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trial [J]. Circ Res, 2014, 114(8): 1292-1301.
|